Reckitt Benckiser Plc Sponsored ADR (RBGLY) –
-
Reckitt Benckiser (RKT:LN) (RBGLY) PT Lowered to GBP48 at HSBC
-
Reckitt Benckiser (RKT:LN) (RBGLY) PT Lowered to GBP5,000 at RBC Capital, 'less upside potential than previously'
-
Reckitt Benckiser (RB/:LN) (RBGLY) PT Lowered to GBP50 at RBC Capital
-
HSBC Reiterates Hold Rating on Reckitt Benckiser (RKT:LN) (RBGLY)
-
Reckitt Benckiser (RKT:LN) (RBGLY) PT Raised to GBP41 at Jefferies
-
Reckitt Benckiser (RKT:LN) (RBGLY) PT Lowered to GBP47 at Morgan Stanley
-
Reckitt Benckiser (RKT:LN) (RBGLY) PT Lowered to GBP48 at CFRA
-
Reckitt Benckiser (RKT:LN) (RBGLY) PT Lowered to GBP55 at Citi, 'catalyst path remains complicated'
-
Reckitt Benckiser (RKT:LN) (RBGLY) PT Lowered to GBP58.80 at Societe Generale
-
Reckitt Benckiser (RKT:LN) (RBGLY) PT Lowered to GBP52 at HSBC
-
Reckitt Benckiser (RB/:LN) (RBGLY) PT Lowered to GBP40 at Jefferies
-
JPMorgan Reiterates Overweight Rating on Reckitt Benckiser (RB/:LN) (RBGLY)
-
Why Reckitt Benckiser stock hit a 10-year low today
-
Reckitt unit hit with $60 million verdict in Enfamil baby formula case in Illinois
-
Reckitt Benckiser (RKT:LN) (RBGLY) PT Lowered to GBP57 at Goldman Sachs
-
Reckitt Benckiser (RKT:LN) (RBGLY) PT Lowered to GBP61 at Societe Generale
-
Reckitt Benckiser (RKT:LN) (RBGLY) PT Lowered to GBP55 at HSBC
-
Reckitt Benckiser (RKT:LN) (RBGLY) PT Lowered to GBP65 at JPMorgan
-
Reckitt Benckiser (RKT:LN) (RBGLY) PT Lowered to GBP58 at Berenberg
-
Jefferies Reiterates Underperform Rating on Reckitt Benckiser (RKT:LN) (RBGLY)
-
Reckitt Benckiser (RB/:LN) (RBGLY) PT Lowered to GBP60 at Barclays
-
UBS Reiterates Buy Rating on Reckitt Benckiser (RB/:LN) (RBGLY)
-
UBS Reiterates Buy Rating on Reckitt Benckiser (RKT:LN) (RBGLY)
-
Exane BNP Paribas Upgrades Reckitt Benckiser (RB/:LN) (RBGLY) to Neutral
-
Reckitt Benckiser (RKT:LN) (RBGLY) PT Lowered to GBP62.40 at Berenberg
-
Reckitt Benckiser (RKT:LN) (RBGLY) PT Lowered to GBP59 at Goldman Sachs
-
Reckitt Benckiser (RKT:LN) (RBGLY) PT Lowered to GBP59 at Deutsche Bank
-
Barclays Reiterates Overweight Rating on Reckitt Benckiser (RKT:LN) (RBGLY)
-
Reckitt Benckiser (RKT:LN) (RBGLY) PT Lowered to GBP75 at UBS
-
Bernstein Upgrades Reckitt Benckiser (RKT:LN) (RBGLY) to Outperform
-
Jefferies Downgrades Reckitt Benckiser (RKT:LN) (RBGLY) to Underperform
-
Reckitt Benckiser (RKT:LN) (RBGLY) PT Lowered to GBP70 at JPMorgan
-
Reckitt Benckiser (RKT:LN) (RBGLY) PT Lowered to GBP69 at Barclays
-
Reckitt Benckiser (RB/:LN) (RBGLY) PT Lowered to GBP60 at Deutsche Bank
-
Morgan Stanley Downgrades Reckitt Benckiser (RKT:LN) (RBGLY) to Equalweight
-
Reckitt Benckiser (RB/:LN) (RBGLY) PT Lowered to GBP75 at RBC Capital
-
Berenberg Downgrades Reckitt Benckiser (RB/:LN) (RBGLY) to Hold
-
HSBC Downgrades Reckitt Benckiser (RKT:LN) (RBGLY) to Hold
-
Reckitt Benckiser (RB/:LN) (RBGLY) PT Lowered to GBP71 at Barclays
-
Reckitt Benckiser (RB/:LN) (RBGLY) PT Raised to GBP77 at UBS
-
Kenvue shares pressured as CVS could remove some of its products from shelves
-
Reckitt Benckiser (RKT:LN) (RBGLY) PT Raised to GBP78 at HSBC
-
Reckitt Benckiser (RKT:LN) (RBGLY) PT Lowered to GBP74 at Barclays
-
Citi Reiterates Buy Rating on Reckitt Benckiser (RKT:LN) (RBGLY)
-
RBC Capital Reiterates Outperform Rating on Reckitt Benckiser (RKT:LN) (RBGLY)
-
Exane BNP Paribas Downgrades Reckitt Benckiser (RB/:LN) (RBGLY) to Underperform
-
Bernstein Reiterates Market Perform Rating on Reckitt Benckiser (RKT:LN) (RBGLY)
-
FDA Issues Warning Letters to Three Infant Formula Manufacturers
-
Reckitt Benckiser (RKT:LN) (RBGLY) PT Lowered to GBP65 at Bernstein
-
Reckitt Benckiser (RB/:LN) (RBGLY) PT Lowered to GBP67 at Morgan Stanley
Back to RBGLY Stock Lookup